NewAmsterdam Pharma
(NASDAQ) NAMS
NewAmsterdam Pharma Financials at a Glance
Market Cap
$3.79B
Revenue (TTM)
$22.50M
Net Income (TTM)
$203.82M
EPS (TTM)
$-1.75
P/E Ratio
-18.89
Dividend
$0.00
Beta (Volatility)
0.49 (Low)
Dividend
$0.00
Beta (Volatility)
0.49 (Low)
Price
$33.04
Volume
35,620
Open
$32.03
Price
$33.04
Volume
35,620
Open
$32.03
Previous Close
$33.04
Daily Range
$31.98 - $33.10
52-Week Range
$14.06 - $42.00
Dividend
$0.00
Beta (Volatility)
0.49 (Low)
Price
$33.04
Volume
35,620
Open
$32.03
Previous Close
$33.04
Daily Range
$31.98 - $33.10
52-Week Range
$14.06 - $42.00
NAMS News
NAMS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout NewAmsterdam Pharma
Industry
Biotechnology
Sector
Health CareEmployees
100
CEO
Michael H. Davidson, MD
Website
www.newamsterdampharma.comHeadquarters
Naarden, 1411 DC, NL
NAMS Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-10%
Net Income Margin
-9%
Return on Equity
-28%
Return on Capital
-33%
Return on Assets
-26%
Earnings Yield
-5.29%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.79B
Shares Outstanding
114.97M
Volume
35.62K
Short Interest
0.00%
Avg. Volume
788.37K
Financials (TTM)
Gross Profit
$22.44M
Operating Income
$225.68M
EBITDA
$242.32M
Operating Cash Flow
$147.78M
Capital Expenditure
$246.00K
Free Cash Flow
$148.03M
Cash & ST Invst.
$636.24M
Total Debt
$202.00K
NewAmsterdam Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$32.00K
-99.7%
Gross Profit
$27.00K
-100.2%
Gross Margin
-84.38%
N/A
Market Cap
$3.79B
N/A
Market Cap/Employee
$55.78M
N/A
Employees
68
N/A
Net Income
$74.92M
+18.7%
EBITDA
$65.92M
+41.0%
Quarterly Fundamentals
Net Cash
$636.04M
-23.7%
Accounts Receivable
$23.15M
+8.7%
Inventory
$0.00
N/A
Long Term Debt
$66.00K
-67.3%
Short Term Debt
$136.00K
-44.7%
Return on Assets
-26.49%
N/A
Return on Invested Capital
-33.02%
N/A
Free Cash Flow
$40.98M
-9.3%
Operating Cash Flow
$40.88M
-9.1%